Bemarituzumab (FUT8-KO)
Product Specifications
Target
FGFR|||Interleukin
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||Immunology/Inflammation
Bioactivity
Bemarituzumab (FUT8-KO) is a humanized IgG1 monoclonal antibody targeting FGFR2b that lacks the FUT8 gene. The Fc domain glycan of the Bemarituzumab (FUT8-KO) antibody is devoid of core fucose, resulting in high affinity for human Fc?RIIIa.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
295953-01 50 mg
O6-Diphenylcarbonyl-N2-isobutyryl-1- (5'-O-DMT-b-D-arabinofuranosyl) guanine
Ask
View Details 
295953-02 100 mg
O6-Diphenylcarbonyl-N2-isobutyryl-1- (5'-O-DMT-b-D-arabinofuranosyl) guanine
Ask
View Details 295953-03 250 mg
O6-Diphenylcarbonyl-N2-isobutyryl-1- (5'-O-DMT-b-D-arabinofuranosyl) guanine
Ask
View Details 295953-04 500 mg
O6-Diphenylcarbonyl-N2-isobutyryl-1- (5'-O-DMT-b-D-arabinofuranosyl) guanine
Ask
View Details 295953-05 1 g
O6-Diphenylcarbonyl-N2-isobutyryl-1- (5'-O-DMT-b-D-arabinofuranosyl) guanine
Ask
View Details